Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JD.Com Inc (JD) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance

JD.Com IncTrade
Norwegian Cruise Line Holdings LtdTrade

Price performance (Past 24H)

Key statistics

JD.Com Inc vs Norwegian Cruise Line Holdings Ltd — how do they compare? JD.Com Inc trades at $27.1 (market cap $36.62B), while Norwegian Cruise Line Holdings Ltd trades at $15.58 (market cap $7.11B). The key difference: JD.Com Inc is far larger — about 5.2× Norwegian Cruise Line Holdings Ltd's market cap, and JD.Com Inc pays a 3.72% dividend while Norwegian Cruise Line Holdings Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold JD.Com Inc for 85 Days and Norwegian Cruise Line Holdings Ltd for 68 Days on average.

JDNCLH
Market Cap
$36.62B$7.11B
Volume
6,571,47722,683,268
Sector
Consumer CyclicalConsumer Cyclical
52-Week High
$34.53$25.02
52-Week Low
$25.19$14.12
Typical Hold Time
85 Days68 Days
Enterprise Value
$19.26B$21.93B
Dividend Yield
3.72%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JD.Com Inc

JD.com trades at $27.17, up 0.5% on the day, with strong analyst support (69.6% buy ratings) and a consensus price target of $35.86 suggesting 32% upside. Recent quarterly earnings have consistently beaten expectations, though revenue growth has slowed to 0.3% year-over-year for 2026. The stock appears fundamentally undervalued with a P/E of 17.9 and P/S of 0.2, while technical indicators show a mixed but slightly bullish bias with key support at $27.

JD offers significant valuation upside potential given its low multiples and strong cash position, but faces headwinds from slowing revenue growth and regulatory scrutiny of its European expansion. The company's robust balance sheet with $234 billion cash provides stability, though competitive pressures in Chinese e-commerce and macroeconomic concerns remain key risks for investors.

Norwegian Cruise Line Holdings Ltd

NCLH trades at $15.57, up 3.46% today, with a bullish technical signal and strong recent earnings beats. The company reported Q2 2026 EPS of $0.48, beating expectations, and expects Q3 results to exceed guidance. Valuation metrics appear attractive with a P/E of 9.39 and P/S of 0.75. Revenue has grown from $4.8B in 2022 to $9.83B in 2025, though net income margin declined to 4.3% from 9.6% in 2024.

The outlook is mixed: analyst consensus is bullish with a $20.86 price target, but the company faces yield pressure and high debt levels. Investment opportunity lies in continued operational recovery and compelling valuation, while risks include Caribbean pricing pressure and significant leverage that could constrain financial flexibility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JD
75% Buy25% Sell
Avg holding period · 85 Days
NCLH
9% Buy91% Sell
Avg holding period · 68 Days

Top news

Latest headlines on both assets

About JD.Com Inc

JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.

Read more on JD →

About Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.

Read more on NCLH →